CSIMarket
 


Casi Pharmaceuticals inc   (CASI)
Other Ticker:  
 

Cumulative Casi Pharmaceuticals Inc 's Leverage Ratio for Trailing Twelve Months Period

CASI's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

CASI Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth -28.75 % -29.39 % -25.03 % 3.63 % -5.38 %
Y / Y Total Liabilities Growth 67.01 % 8.23 % 19.12 % 25.57 % 24.81 %
Leverage Ratio for Trailing Twelve Months Period 0.47 0.37 0.34 0.3 0.29
Total Ranking # 1419 # 1484 # 1401 # 1413 # 1072
Seq. Equity Growth -7.82 % -10.73 % -11.26 % -2.43 % -8.64 %
Seq. Total Liabilities Growth 52.78 % -5.17 % 1.68 % 13.37 % -1 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to net new borrowings of 52.78%, Leverage Ratio for Trailing Twelve Months Period improved to 0.47, above Casi Pharmaceuticals Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 153 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Casi Pharmaceuticals Inc . While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 1419, from total ranking in previous quarter at 1484.

What is Leverage Ratio?
Who are CASI's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 154
Sector # 598
S&P 500 # 1417


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.79 0.41 0.05
(Sep 30 2022)   (Dec 31 2018)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Educational Development Corporation  1.29 
Volitionrx Limited  1.27 
Allied Healthcare Products inc   1.26 
Pulse biosciences inc   1.21 
Capstone Companies Inc   1.16 
Biogen Inc   1.11 
Isoplexis Corporation  1.10 
Perkinelmer Inc  1.07 
Lsi Industries Inc   1.07 
Fennec Pharmaceuticals Inc   1.05 
Armata Pharmaceuticals Inc   1.02 
Agilent Technologies inc.  1.02 
Windtree Therapeutics Inc  1.00 
Harvard Bioscience Inc  1.00 
Livento Group Inc   0.99 
Oncocyte Corporation  0.98 
Idera Pharmaceuticals Inc   0.96 
Allena Pharmaceuticals Inc.  0.95 
Applied Genetic Technologies Corporation  0.94 
Meiragtx Holdings Plc  0.94 
Sangamo Therapeutics Inc   0.92 
Heart Test Laboratories Inc.  0.91 
Outlook Therapeutics Inc.  0.91 
X4 Pharmaceuticals Inc  0.90 
Pluri Inc   0.87 
Curis Inc   0.87 
Logicbio Therapeutics Inc   0.87 
Genocea Biosciences Inc   0.86 
Achieve Life Sciences Inc   0.86 
Palisade Bio Inc   0.82 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WU's Profile

Stock Price

WU's Financials

Business Description

Fundamentals

Charts & Quotes

WU's News

Suppliers

WU's Competitors

Customers & Markets

Economic Indicators

WU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071